Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Ferraldeschi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
F1000Research|August 23, 2018
Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle studyAndrea Tacchella, Silvia Romano, Michela Ferraldeschi, et al.
Frontiers in Neurology|March 7, 2019
Genome-Wide Multiple Sclerosis Association Data and CoagulationSara La Starza, Michela Ferraldeschi, Maria Chiara Buscarinu, et al.
Clinical Neurology and Neurosurgery|July 5, 2018
Corrigendum to "Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia" [Clin. Neurol. Neurosurg. 168 (May) (2018) 60-63]Giulia Coarelli, Silvia Romano, Lorena Travaglini, et al.
Clinical Neurology and Neurosurgery|March 11, 2018
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegiaGiulia Coarelli, Silvia Romano, Lorena Travaglini, et al.
Genes|January 18, 2020
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS EtiopathogenesisRosella Mechelli, Renato Umeton, Grazia Manfrè, et al.
Frontiers in Immunology|September 27, 2019
The Contribution of Gut Barrier Changes to Multiple Sclerosis PathophysiologyMaria Chiara Buscarinu, Arianna Fornasiero, Silvia Romano, et al.
Frontiers in Neurology|May 24, 2021
Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot StudyMichela Ferraldeschi, Silvia Romano, Simona Giglio, et al.
The Lancet. Neurology|September 1, 2015
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trialSilvia Romano, Giulia Coarelli, Christian Marcotulli, et al.
Frontiers in Neurology|August 6, 2019
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferioritySilvia Romano, Michela Ferraldeschi, Francesca Bagnato, et al.
International Journal of Molecular Sciences|October 27, 2022
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot StudySilvia Romano, Carmela Romano, Martina Peconi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
F1000Research|August 23, 2018
Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle studyAndrea Tacchella, Silvia Romano, Michela Ferraldeschi, et al.
Frontiers in Neurology|March 7, 2019
Genome-Wide Multiple Sclerosis Association Data and CoagulationSara La Starza, Michela Ferraldeschi, Maria Chiara Buscarinu, et al.
Clinical Neurology and Neurosurgery|July 5, 2018
Corrigendum to "Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia" [Clin. Neurol. Neurosurg. 168 (May) (2018) 60-63]Giulia Coarelli, Silvia Romano, Lorena Travaglini, et al.
Clinical Neurology and Neurosurgery|March 11, 2018
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegiaGiulia Coarelli, Silvia Romano, Lorena Travaglini, et al.
Genes|January 18, 2020
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS EtiopathogenesisRosella Mechelli, Renato Umeton, Grazia Manfrè, et al.
Frontiers in Immunology|September 27, 2019
The Contribution of Gut Barrier Changes to Multiple Sclerosis PathophysiologyMaria Chiara Buscarinu, Arianna Fornasiero, Silvia Romano, et al.
Frontiers in Neurology|May 24, 2021
Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot StudyMichela Ferraldeschi, Silvia Romano, Simona Giglio, et al.
The Lancet. Neurology|September 1, 2015
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trialSilvia Romano, Giulia Coarelli, Christian Marcotulli, et al.
Frontiers in Neurology|August 6, 2019
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferioritySilvia Romano, Michela Ferraldeschi, Francesca Bagnato, et al.
International Journal of Molecular Sciences|October 27, 2022
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot StudySilvia Romano, Carmela Romano, Martina Peconi, et al.
Pageof 2